Skip to content

Clinical trials

Active, not recruiting Lupus Erythematosus, Systemic trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Status: Active, not recruiting Country / region: China Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20213
20225
20234
20245
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Biogen2
Chinese SLE Treatment And Research Group2
AbbVie1
AstraZeneca1
Beeline Medicines Corporation1
Beijing Mabworks Biotech Co., Ltd.1
Bristol-Myers Squibb1
Genrix (Shanghai) Biopharmaceutical Co., Ltd.1
Gracell Biotechnologies (Shanghai) Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic24
Autoimmune Diseases3
Connective Tissue Diseases2
Immune System Diseases2
Lupus Erythematosus, Cutaneous2
Lupus Erythematosus, Discoid2
Lupus Nephritis2
Scleroderma, Systemic2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
Immunoglobulin G4-Related Disease1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.